3D structures from the PDB for "Carbonic anhydrase 1/12/13/14/2/3/4/5A, mitochondrial/5B, mitochondrial/6/7/9" AND "BDBM10880"
(Proteins have >= 85% sequence identity and ligands are exact matches)

Seq IdentityJmol DisplayPDB Title
6YMA100%JmolMICROED STRUCTURE OF ACETAZOLAMIDE-BOUND HUMAN CARBONIC ANHYDRASE II
5JN8100%JmolCRYSTAL STRUCTURE FOR THE COMPLEX OF HUMAN CARBONIC ANHYDRASE IV AND ACETAZOLAMIDE
4G0C100%JmolNEUTRON STRUCTURE OF ACETAZOLAMIDE-BOUND HUMAN CARBONIC ANHYDRASE II REVEAL MOLECULAR DETAILS OF DRUG BINDING.
3HS4100%JmolHUMAN CARBONIC ANHYDRASE II COMPLEXED WITH ACETAZOLAMIDE
4LU3100%JmolTHE CRYSTAL STRUCTURE OF THE HUMAN CARBONIC ANHYDRASE XIV
6QEB100%JmolASSESSMENT OF A LARGE ENZYME-DRUG COMPLEX BY PROTON-DETECTED SOLID- STATE NMR WITHOUT DEUTERATION
3V2M100%JmolEFFECT OF SUCROSE AND GLYCEROL AS CRYOPROTECTANS, ON THE INHIBITION OF HUMAN CARBONIC ANHYDRASE II
3V2J100%JmolEFFECT OF SUCROSE AND GLYCEROL AS CRYOPROTECTANS, ON THE INHIBITION OF HUMAN CARBONIC ANHYDRASE II
3CZV100%JmolCRYSTAL STRUCTURE OF THE HUMAN CARBONIC ANHYDRASE XIII IN COMPLEX WITH ACETAZOLAMIDE
3W6H100%JmolCRYSTAL STRUCTURE OF 19F PROBE-LABELED HCAI IN COMPLEX WITH ACETAZOLAMIDE
1JD0>99%JmolCRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN CARBONIC ANHYDRASE XII COMPLEXED WITH ACETAZOLAMIDE
1ZSB>99%JmolCARBONIC ANHYDRASE II MUTANT E117Q, TRANSITION STATE ANALOGUE ACETAZOLAMIDE
1YDD>99%JmolSTRUCTURAL BASIS OF INHIBITOR AFFINITY TO VARIANTS OF HUMAN CARBONIC ANHYDRASE II
1YDA>99%JmolSTRUCTURAL BASIS OF INHIBITOR AFFINITY TO VARIANTS OF HUMAN CARBONIC ANHYDRASE II
1YDB>99%JmolSTRUCTURAL BASIS OF INHIBITOR AFFINITY TO VARIANTS OF HUMAN CARBONIC ANHYDRASE II
2H4N>99%JmolH94N CARBONIC ANHYDRASE II COMPLEXED WITH ACETAZOLAMIDE
3ML5>99%JmolCRYSTAL STRUCTURE OF THE C183S/C217S MUTANT OF HUMAN CA VII IN COMPLEX WITH ACETAZOLAMIDE
3DC3>99%JmolUSE OF CARBONIC ANHYDRASE II, IX ACTIVE-SITE MIMIC, FOR THE PURPOSE OF SCREENING INHIBITORS FOR POSSIBLE ANTI-CANCER PROPERTIES
4K0S98%JmolSTRUCTURE OF HCAIX MIMIC (HCAII WITH 5 MUTATIONS IN ACTIVE SITE) IN COMPLEX WITH ACETAZOLAMIDE